LipiFlow

Innovative Dry Eye Disease Treatment for Meibomian Gland Disease (MGD)

The burning question for millions, “Is it Dry Eye or Meimobian Gland Disease (MGD)?” Have you ever been told you have Dry Eye with symptoms like tired, red, burning, scratchy, watery eyes, or fluctuating vision? Here’s a fact. Roughly 90% of all those who have been diagnosed with dry eye have a condition called Meibomian Gland Dysfunction. Most refer to it as MGD and the good news is that it is treatable.

What is MGD? Your eyes produce tears from glands called lacrimal glands. This is the watery layer of the eye. Your eyes also produce essential oils from the Meibomian glands, located in the eyelids. This oil protects the watery layer of the eyes. If there is a lack of oil, the watery layer evaporates and the eyes are left unprotected.

Simply put, your tear production may be healthy but blocked Meibomian glands lead to a lack of oil production causing the tears to evaporate and those annoying dry eye symptoms. If left untreated, these blocked glands can begin to shrink and deteriorate making the damage irreparable. This is why addressing MGD sooner than later is your best option.

The good news is LipiFlow. Through ground breaking innovations, MGD can now be treated with LipiFlow. LipiFlow is a proven, in-office, FDA cleared treatment that unblocks the Meibomian glands and restores natural oil production, so the watery portion of your tears no longer evaporates. That means that millions who have been diagnosed with Dry Eye can enjoy everyday activities without bothersome dry eye symptoms.

So, is it dry eye or MGD? Ask if you are a candidate for LipiFlow.